Lung cancer: potential targets for immunotherapy

E Tartour, L Zitvogel - The Lancet Respiratory Medicine, 2013 - thelancet.com
Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …
被引用次数：100 相关文章

Lung cancer: potential targets for immunotherapy.

E Tartour, L Zitvogel - The Lancet. Respiratory Medicine, 2013 - europepmc.org
Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …

Lung cancer: potential targets for immunotherapy

E Tartour, L Zitvogel - The Lancet Respiratory Medicine, 2013 - Elsevier
Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …

Lung cancer: potential targets for immunotherapy

E Tartour, L Zitvogel - Lancet, 2013 - thelancet.com
Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …

Lung cancer: potential targets for immunotherapy

E Tartour, L Zitvogel - The Lancet. Respiratory medicine, 2013 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …

Lung cancer: potential targets for immunotherapy

E Tartour, L Zitvogel - The Lancet Respiratory Medicine, 2013 - infona.pl
Lung cancer is the most common cause of cancer-related mortality worldwide and a
therapeutic challenge. Recent success with antibodies blocking immune checkpoints in non …